Assembly Actions -
Lowercase Senate Actions - UPPERCASE |
|
---|---|
Jan 13, 2025 |
referred to health |
Senate Bill S1618
2025-2026 Legislative Session
Sponsored By
(D, WF) 33rd Senate District
Current Bill Status - In Senate Committee Health Committee
- Introduced
-
- In Committee Assembly
- In Committee Senate
-
- On Floor Calendar Assembly
- On Floor Calendar Senate
-
- Passed Assembly
- Passed Senate
- Delivered to Governor
- Signed By Governor
Actions
co-Sponsors
(D, WF) 56th Senate District
(D, WF) 48th Senate District
2025-S1618 (ACTIVE) - Details
- Current Committee:
- Senate Health
- Law Section:
- Public Health Law
- Laws Affected:
- Add Art 2-A Title IV §§282 - 285, Pub Health L
- Versions Introduced in Other Legislative Sessions:
-
2019-2020:
S9020
2021-2022: S3048
2023-2024: S4786
2025-S1618 (ACTIVE) - Summary
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
2025-S1618 (ACTIVE) - Sponsor Memo
BILL NUMBER: S1618 SPONSOR: RIVERA TITLE OF BILL: An act to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" PURPOSE: Enacts the "New York Affordable Drug Manufacturing Act". SUMMARY OF SPECIFIC PROVISIONS: Section 1 provides a short title, the "New York Affordable Drug Manufac- turing Act." Section 2 amends Article 2-A of the Public Health Law by adding a new title IV, the New York Affordable Drug Manufacturing Act, which will help increase patient access to affordable drugs. This section provides definitions for the terms "generic prescription drug" and "partner- ships," and includes language regarding criteria for the commissioner to
2025-S1618 (ACTIVE) - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 1618 2025-2026 Regular Sessions I N S E N A T E January 13, 2025 ___________ Introduced by Sens. RIVERA, COONEY, MAY -- read twice and ordered print- ed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to enacting the "New York affordable drug manufacturing act" THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Short title. This act shall be known and may be cited as the "New York affordable drug manufacturing act". § 2. Article 2-A of the public health law is amended by adding a new title IV to read as follows: TITLE IV NEW YORK AFFORDABLE DRUG MANUFACTURING ACT SECTION 282. DEFINITIONS. 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF GENERIC PRESCRIPTION DRUGS. 284. REPORTING. 285. PROPRIETARY INFORMATION. § 282. DEFINITIONS. AS USED IN THIS TITLE, THE FOLLOWING TERMS SHALL HAVE THE FOLLOWING MEANINGS: 1. "GENERIC PRESCRIPTION DRUG" MEANS A DRUG THAT IS APPROVED PURSUANT TO AN APPLICATION SUBMITTED UNDER SUBDIVISION (J) OF SECTION 355 OF THE FEDERAL FOOD, DRUG, AND COSMETIC ACT (21 U.S.C. SEC. 301 ET SEQ.), OR A BIOSIMILAR, AS DEFINED UNDER THE FEDERAL PUBLIC HEALTH SERVICE ACT (42 U.S.C. SEC. 262) THAT IS NOT UNDER PATENT. 2. "PARTNERSHIPS" MEANS AGREEMENTS FOR THE PROCUREMENT OF GENERIC PRESCRIPTION DRUGS BY WAY OF CONTRACTS OR PURCHASING BY A PAYER, STATE GOVERNMENTAL AGENCY, GROUP PURCHASING ORGANIZATION, NONPROFIT ORGANIZA- TION, OR OTHER ENTITY. § 283. PARTNERSHIPS; PRODUCTION AND DISTRIBUTION OF GENERIC PRESCRIPTION DRUGS. 1. (A) THE COMMISSIONER SHALL ENTER INTO PARTNER- SHIPS, CONSISTENT WITH PARAGRAPH (B) OF SUBDIVISION TWO OF THIS SECTION, EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD04133-01-5
Comments
Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.
Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.
Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.